Every 8-K that Retractable Tech (RVP) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow RVP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RVP filings page.
Retractable Technologies, Inc. reported weaker core operating results for the three and six months ended June 30, 2026. Second-quarter net sales were $7.2 million, down from $10.4 million a year earlier, with an unchanged operating loss of $5.1 million. For the first half of 2026, net sales were $14.4 million versus $18.7 million in 2025 and the operating loss widened to $11.3 million from $9.8 million, driven by lower EasyPoint® needle volumes and higher operating expenses, including donation expense.
Despite operating losses, second-quarter net income was $2.8 million, and the six-month net loss was $(1.4) million, both including a $6.4 million realized gain on the sale of equity securities. Domestic production rose to 42.4% of units manufactured in the first half of 2026 compared to 38% in 2025, and tariff expenses declined to $46 thousand in Q2 as mitigation and increased domestic production took effect. A previously disclosed April 2026 reduction in force is expected to generate future cost savings.
Retractable Technologies, Inc. announced that its Board of Directors has declared cash dividends on its Series II Class B and Series III Class B Convertible Preferred Stock. The declared dividends are $39,050.00 for Series II Class B and $18,561.25 for Series III Class B.
These dividends have accrued at a rate of $1.00 per share per annum for the period from April 1, 2026 through June 30, 2026. They will be paid on July 20, 2026 to shareholders of record as of the close of business on July 10, 2026.
Retractable Technologies, Inc. reported weaker results for the quarter ended March 31, 2026. Total net sales were $7.2 million, down from $8.3 million a year earlier, and the company posted an operating loss of $6.2 million versus $4.7 million last year, driven by lower average selling prices and higher donation-related expenses.
Domestic revenues fell 20.0% and now represent a smaller share of total sales, while international revenues rose 42.4%, helped by EasyPoint® needle demand, lifting total unit volume 3.6%. Operating expenses increased 14%, with about $900 thousand tied to non-recurring consulting and charitable product donations.
Net loss for the quarter was $4.2 million. Tariff costs dropped to about $11.6 thousand as 39% of products were produced domestically. In April 2026, the company reduced its workforce by approximately 16%, expecting about $2.2 million in annual wage and benefit savings, offset by roughly $122 thousand in one-time separation payments.
Retractable Technologies, Inc. reported the results of its Annual Meeting of Shareholders, held as a virtual meeting on May 8, 2026. Shareholders elected three Class 2 directors nominated by the board. Thomas J. Shaw received 20,777,201 votes for and 283,312 withheld, Walter O. Bigby, Jr. received 20,443,325 for and 617,188 withheld, and John W. Fort III received 20,707,800 for and 352,713 withheld, with no abstentions or broker non-votes reported for these items.
Retractable Technologies, Inc. has reduced its workforce by approximately 16%. The company expects this move to save an estimated $2.2 million in annual wages and employment benefits, equal to about 13% of total estimated workforce costs, partly offset by one-time separation payments of roughly $122,000.
About 58% of the targeted payroll reduction is in manufacturing or manufacturing support roles, with the rest in sales and sales support. The company links this restructuring to its ongoing shift toward strengthening domestic production and improving manufacturing efficiency to reduce reliance on Chinese contract manufacturers and mitigate the financial impact of tariffs on imports from China.
Retractable Technologies, Inc. reported 2025 results showing revenue growth but continued operating losses, and announced dividends on its Series II and III Class B preferred stock. Revenues rose 15.8% to about $38.3 million from $33.0 million, driven by higher VanishPoint® and EasyPoint® needle sales, especially internationally where revenue increased 64.0%.
Total operating expenses were $21.2 million, resulting in a 2025 loss from operations of $21.2 million, similar to the prior year. Cash decreased by $1.6 million to $2.6 million at year-end, while the company held $34.4 million in debt and equity securities. Management notes that 62.6% of products came from China and that a 120% tariff rate on many imported syringe and needle products, along with about $1.8 million of tariff expense in 2025, is expected to continue having a material impact.
The board declared dividends of $39,050.00 on Series II Class B and $18,561.25 on Series III Class B Convertible Preferred Stock for the period January 1 through March 31, 2026, at $1.00 per share per year. These dividends will be paid on April 20, 2026 to holders of record on April 10, 2026.
Retractable Technologies, Inc. disclosed that on December 30, 2025 it issued a press release announcing the declaration of a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The announcement applies only to these preferred stock classes and does not mention the common stock. The details of the dividend itself are contained in the attached press release identified as Exhibit 99.
Retractable Technologies, Inc. (RVP) filed a Form 8‑K announcing it issued two press releases. One release reports results for the periods ended September 30, 2025, and the other announces the Company’s receipt of an Innovative Technology designation from Vizient®.
The earnings release is furnished as Exhibit 99.1, and the Vizient designation release is furnished as Exhibit 99.2. RVP’s common stock trades on the NYSE American under the symbol RVP.
Retractable Technologies, Inc. filed a Form 8-K to report that it has declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The company disclosed this action through a press release that is attached as Exhibit 99 to the report, ensuring these preferred shareholders are informed about the new dividend.
The filing is limited to announcing this dividend declaration and does not include common stock dividend details, financial results, or other operational updates.
Retractable Technologies, Inc. filed an Form 8-K dated August 14, 2025 disclosing an Item 8.01 other event and Item 9.01 exhibits. The filing attaches a press release that announces results for the periods ended June 30, 2025. The document is signed by John W. Fort III, Vice President, Chief Financial Officer, and Chief Accounting Officer, and lists Little Elm, Texas as the company's principal executive office.